VX-765

Generic Name
VX-765
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
00OLE78529
Background

VX-765 is the orally available prodrug of a potent and selective competitive inhibitor of ICE/caspase-1 (VRT-043198). VX-765 is currently under clinical development for the treatment of inflammatory and autoimmune conditions, as it blocks the hypersensitive response to an inflammatory stimulus.

Indication

Investigated for use/treatment in inflammatory disorders (unspecified) and psoriasis and psoriatic disorders.

Associated Conditions
-
Associated Therapies
-
nature.com
·

NIS-Seq enables cell-type-agnostic optical perturbation screening

CROPseq-iT7 backbone and Brunello library were cloned, tissue culture conditions for various cell lines were established, and library transduction and quality control were performed. NIS-Seq perturbation screens were conducted, and imaging and image analysis were detailed. Single-gene perturbation cell lines were generated for validation, and primary human macrophages were differentiated, transduced, and nucleofected. Inflammasome stimulation and human epidermal sheet preparation, transduction, and sequencing were also described. Zero-knowledge image analysis using deep learning was performed, and ethics statements were included.
© Copyright 2024. All Rights Reserved by MedPath